Works matching IS 11732563 AND DT 2019 AND VI 39 AND IP 3
Results: 9
Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 309, doi. 10.1007/s40261-019-00752-1
- By:
- Publication type:
- Article
Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 253, doi. 10.1007/s40261-019-00751-2
- By:
- Publication type:
- Article
Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 331, doi. 10.1007/s40261-019-00750-3
- By:
- Publication type:
- Article
Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 241, doi. 10.1007/s40261-018-00745-6
- By:
- Publication type:
- Article
Opioid Use and Pain Control in the Elderly After Elective or Urgent Orthopaedic Surgery: A Retrospective Cohort Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 301, doi. 10.1007/s40261-018-00744-7
- By:
- Publication type:
- Article
Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 233, doi. 10.1007/s40261-018-00743-8
- By:
- Publication type:
- Article
HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 285, doi. 10.1007/s40261-018-0739-9
- By:
- Publication type:
- Article
Switching of Oral P2Y<sub>12</sub> Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 275, doi. 10.1007/s40261-018-0736-z
- By:
- Publication type:
- Article
Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 3, p. 319, doi. 10.1007/s40261-018-0735-0
- By:
- Publication type:
- Article